120 related articles for article (PubMed ID: 10492059)
1. Dextromethorphan O-demethylation polymorphism in an African-American population.
He N; Daniel HI; Hajiloo L; Shockley D
Eur J Clin Pharmacol; 1999 Aug; 55(6):457-9. PubMed ID: 10492059
[TBL] [Abstract][Full Text] [Related]
2. Frequency distribution of dextromethorphan O-demethylation in a Greek population.
Kimiskidis VK; Niopas I; Firinidis PD; Kanaze FI; Gabrieli C; Kazis D; Papagiannopoulos S; Kazis A
Int J Clin Pharmacol Ther; 2005 Mar; 43(3):150-3. PubMed ID: 15792399
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P
Dhuya M; Pal MM; Hazra A; Chatterjee S; Gogtay N
Indian J Pharmacol; 2020; 52(3):189-195. PubMed ID: 32874001
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphism of CYP2D6 in North Indian subjects.
Lamba V; Lamba JK; Dilawari JB; Kohli KK
Eur J Clin Pharmacol; 1998; 54(9-10):787-91. PubMed ID: 9923585
[TBL] [Abstract][Full Text] [Related]
5. CYP2D6 phenotyping with dextromethorphan.
Wojtczak A; Rychlik-Sych M; Krochmalska-Ulacha E; Skretkowicz J
Pharmacol Rep; 2007; 59(6):734-8. PubMed ID: 18195464
[TBL] [Abstract][Full Text] [Related]
6. Unique CYP2D6 activity distribution and genotype-phenotype discordance in black Americans.
Gaedigk A; Bradford LD; Marcucci KA; Leeder JS
Clin Pharmacol Ther; 2002 Jul; 72(1):76-89. PubMed ID: 12152006
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the CYP2D6 gene polymorphism and enzyme activity in African-Americans in southern California.
Wan YJ; Poland RE; Han G; Konishi T; Zheng YP; Berman N; Lin KM
Pharmacogenetics; 2001 Aug; 11(6):489-99. PubMed ID: 11505219
[TBL] [Abstract][Full Text] [Related]
8. Dextromethorphan metabolic phenotyping in an Iranian population.
Afshar M; Rouini M; Ala S
Eur J Clin Pharmacol; 2005 Feb; 60(12):849-54. PubMed ID: 15657780
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cytochrome P450 2D6 phenotyping in healthy adult Western Indians.
Gogtay NJ; Mali NB; Iyer K; Kadam PP; Sridharan K; Shrimal D; Thatte UM
Indian J Pharmacol; 2014; 46(3):266-9. PubMed ID: 24987171
[TBL] [Abstract][Full Text] [Related]
10. Dextromethorphan metabolic phenotyping in a Chinese population.
Cai WM; Chen B; Liu YX; Chu X
Zhongguo Yao Li Xue Bao; 1997 Sep; 18(5):441-4. PubMed ID: 10322937
[TBL] [Abstract][Full Text] [Related]
11. High frequency of CYP2D6 poor and "intermediate" metabolizers in black populations: a review and preliminary data.
Bradford LD; Gaedigk A; Leeder JS
Psychopharmacol Bull; 1998; 34(4):797-804. PubMed ID: 10513455
[TBL] [Abstract][Full Text] [Related]
12. CYP2D6 polymorphism in a Gabonese population: contribution of the CYP2D6*2 and CYP2D6*17 alleles to the high prevalence of the intermediate metabolic phenotype.
Panserat S; Sica L; Gérard N; Mathieu H; Jacqz-Aigrain E; Krishnamoorthy R
Br J Clin Pharmacol; 1999 Jan; 47(1):121-4. PubMed ID: 10073750
[TBL] [Abstract][Full Text] [Related]
13. Determination of dextromethorphan metabolizer phenotype in healthy volunteers.
Hildebrand M; Seifert W; Reichenberger A
Eur J Clin Pharmacol; 1989; 36(3):315-8. PubMed ID: 2744072
[TBL] [Abstract][Full Text] [Related]
14. Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylation.
Jones DR; Gorski JC; Haehner BD; O'Mara EM; Hall SD
Clin Pharmacol Ther; 1996 Oct; 60(4):374-84. PubMed ID: 8873685
[TBL] [Abstract][Full Text] [Related]
15. Dextromethorphan O-demethylation polymorphism in the Uruguayan population.
Estevez F; Giusti M; Parrillo S; Oxandabarat J
Eur J Clin Pharmacol; 1997; 52(5):417-8. PubMed ID: 9272415
[No Abstract] [Full Text] [Related]
16. CYP2D6-related oxidation polymorphism in a Canadian Inuit population.
Jurima-Romet M; Foster BC; Casley WL; Rode A; Vloshinsky P; Huang HS; Geertsen S
Can J Physiol Pharmacol; 1997 Mar; 75(3):165-72. PubMed ID: 9164697
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of CYP2D6 phenotype in the Yoruba Nigerian population.
Adedeji WA; Igbinoba SI; Fakeye TO; Oladosu IA; Fehintola FA; Ma Q; Morse GD
Expert Rev Clin Pharmacol; 2017 Oct; 10(10):1145-1152. PubMed ID: 28786716
[TBL] [Abstract][Full Text] [Related]
18. Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes.
Kubota T; Yamaura Y; Ohkawa N; Hara H; Chiba K
Br J Clin Pharmacol; 2000 Jul; 50(1):31-4. PubMed ID: 10886115
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of dextromethorphan oxidation in Polish population.
Skretkowicz J; Wojtczak A; Rychlik-Sych M
Acta Pol Pharm; 2008; 65(5):611-5. PubMed ID: 19051610
[TBL] [Abstract][Full Text] [Related]
20. Dextromethorphan O-demethylation and dextrorphan glucuronidation in a French population.
Duché JC; Quérol-Ferrer V; Barré J; Mésangeau M; Tillement JP
Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):392-8. PubMed ID: 8225685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
